20 results
DRS
MAIA
MAIA Biotechnology Inc
1 Jun 23
Draft registration statement
12:00am
Glioblastoma Multiforme (GBM)
Bladder Cancer
Neuroblastoma
head & Neck Squamous Cell Carcinoma (HNSCC)
Lymphoma (high grade)
Gastric Cancer
Chronic Myeloid … Leukemia (CML)
Melanoma
Chronic Lymphocytic Leukemia (CLL)
Cervical Cancer
Acute Myeloid Leukemia (AML)
Sources: A Survey of Telomerase Activity
424B4
MAIA
MAIA Biotechnology Inc
25 Apr 23
Prospectus supplement with pricing info
7:45pm
(GBM)
Bladder Cancer
Neuroblastoma
head & Neck Squamous Cell Carcinoma (HNSCC)
Lymphoma (high grade)
Gastric Cancer
Chronic Myeloid Leukemia (CML … )
Melanoma
Chronic Lymphocytic Leukemia (CLL)
Cervical Cancer
Acute Myeloid Leukemia (AML)
Sources: A Survey of Telomerase Activity in Human Cancer – JW
DEF 14A
13kveih4brp
19 Apr 23
Definitive proxy
4:06pm
DRS
7g1cu5d52bxz er3
23 Dec 22
Draft registration statement
12:00am
424B4
x2pmdg1r qr1
29 Jul 22
Prospectus supplement with pricing info
8:31am
S-1
x496sb
8 Apr 22
IPO registration
8:21pm
DRS/A
rpmk pbblg
22 Dec 21
Draft registration statement (amended)
12:00am
DRS
ecjiinnifcqfcsom4z
15 Oct 21
Draft registration statement
12:00am
- Prev
- 1
- Next